Spero Therapeutics
SPRO
$1.54
Share price
8.80%
Change (1 day)
-16.49%
Change (1 year)
Categories
Spero Therapeutics (SPRO) - Net assets
Net assets on the balance sheet as of December 2023 : $0.10 B
According to Spero Therapeutics's latest financial reports the company has $0.10 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Spero Therapeutics - Net assets on balance sheet (from 2016 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | 40.77% |
| 2022-12-31 | $75.93 M | -13.99% |
| 2021-12-31 | $88.28 M | -33.13% |
| 2020-12-31 | $0.13 B | 77.06% |
| 2019-12-31 | $74.57 M | -35.63% |
| 2018-12-31 | $0.11 B | 36.37% |
| 2017-12-31 | $84.95 M | 1235.59% |
| 2016-12-31 | $6.36 M | -2575.1% |
| 2015-12-31 | $-0.26 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 IBM IBM | $22.61 B | 21,054.60% | 🇺🇸 USA |
 Thomson Reuters
TRI | $11.06 B | 10,250.44% | 🇨🇦 Canada |
 Franklin Covey FC | $70.82 M | -33.74% | 🇺🇸 USA |